|
1
|
Wang Z, Li Y, Banerjee S and Sarkar FH:
Exploitation of the Notch signaling pathway as a novel target for
cancer therapy. Anticancer Res. 28:3621–3630. 2008.
|
|
2
|
Rizzo P, Osipo C, Foreman K, Golde T,
Osborne B and Miele L: Rational targeting of Notch signaling in
cancer. Oncogene. 27:5124–5131. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gallahan D, Jhappan C, Robinson G, et al:
Expression of a truncated Int3 gene in developing secretory mammary
epithelium specifically retards lobular differentiation resulting
in tumorigenesis. Cancer Res. 56:1775–1785. 1996.PubMed/NCBI
|
|
4
|
Kiaris H, Politi K, Grimm LM, et al:
Modulation of notch signaling elicits signature tumors and inhibits
hras1-induced oncogenesis in the mouse mammary epithelium. Am J
Pathol. 165:695–705. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bao B, Wang Z, Ali S, et al: Notch-1
induces epithelial-mesenchymal transition consistent with cancer
stem cell phenotype in pancreatic cancer cells. Cancer Lett.
307:26–36. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Artavanis-Tsakonas S, Rand MD and Lake RJ:
Notch signaling: cell fate control and signal integration in
development. Science. 284:770–776. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shook D and Keller R: Mechanisms,
mechanics and function of epithelial-mesenchymal transitions in
early development. Mech Dev. 120:1351–1383. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Levayer R and Lecuit T: Breaking down EMT.
Nat Cell Biol. 10:757–759. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Duband JL, Blavet C, Jarov A and
Fournier-Thibault C: Spatio-temporal control of neural epithelial
cell migration and epithelium-to-mesenchyme transition during avian
neural tube development. Dev Growth Differ. 51:25–44. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Clevers H: The cancer stem cell: premises,
promises and challenges. Nat Med. 17:313–319. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mani SA, Guo W, Liao MJ, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Baker SJ, Rane SG and Reddy EP:
Hematopoietic cytokine receptor signaling. Oncogene. 26:6724–6737.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Groner B, Lucks P and Borghouts C: The
function of Stat3 in tumor cells and their microenvironment. Semin
Cell Dev Biol. 19:341–350. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Berishaj M, Gao SP, Ahmed S, et al: Stat3
is tyrosine-phosphorylated through the interleukin-6/glycoprotein
130/Janus kinase pathway in breast cancer. Breast Cancer Res.
9:R322007. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Marotta LL, Almendro V, Marusyk A, et al:
The JAK2/STAT3 signaling pathway is required for growth of CD44(+)
CD24(−) stem cell-like breast cancer cells in human tumors. J Clin
Invest. 121:2723–2735. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Barnes RM and Firulli AB: A twist of
insight - the role of Twist-family bHLH factors in development. Int
J Dev Biol. 53:909–924. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Puisieux A, Valsesia-Wittmann S and
Ansieau S: A twist for survival and cancer progression. Br J
Cancer. 94:13–17. 2006. View Article : Google Scholar
|
|
20
|
Zeisberg M and Neilson EG: Biomarkers for
epithelial-mesenchymal transitions. J Clin Invest. 119:1429–1437.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Watanabe O, Imamura H, Shimizu T, et al:
Expression of twist and wnt in human breast cancer. Anticancer Res.
24:3851–3856. 2004.
|
|
22
|
Vesuna F, Lisok A, Kimble B and Raman V:
Twist modulates breast cancer stem cells by transcriptional
regulation of CD24 expression. Neoplasia. 11:1318–1328.
2009.PubMed/NCBI
|
|
23
|
Anant S, Roy S and VijayRaghavan K: Twist
and Notch negatively regulate adult muscle differentiation in
Drosophila. Development. 125:1361–1369. 1998.PubMed/NCBI
|
|
24
|
Tapanes-Castillo A and Baylies MK: Notch
signaling patterns Drosophila mesodermal segments by regulating the
bHLH transcription factor twist. Development. 131:2359–2372. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hsu KW, Hsieh RH, Huang KH, et al:
Activation of the Notch1/STAT3/Twist signaling axis promotes
gastric cancer progression. Carcinogenesis. 33:1459–1467. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li Y, Wang L, Pappan L, Galliher-Beckley A
and Shi J: IL-1beta promotes stemness and invasiveness of colon
cancer cells through Zeb1 activation. Mol Cancer. 11:872012.
View Article : Google Scholar
|
|
27
|
Liu ZL, Li Y, Kong QY, et al:
Immunohistochemical profiling of Wnt, NF-kappaB, Stat3 and Notch
signaling in human epidermal tumors. J Dermatol Sci. 52:133–136.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Koch U, Lehal R and Radtke F: Stem cells
living with a Notch. Development. 140:689–704. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Osanyingbemi-Obidi J, Dobromilskaya I,
Illei PB, Hann CL and Rudin CM: Notch signaling contributes to lung
cancer clonogenic capacity in vitro but may be circumvented in
tumorigenesis in vivo. Mol Cancer Res. 9:1746–1754. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bolos V, Mira E, Martinez-Poveda B, et al:
Notch activation stimulates migration of breast cancer cells and
promotes tumor growth. Breast Cancer Res. 15:R542013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Espinoza I and Miele L: Deadly crosstalk:
Notch signaling at the intersection of EMT and cancer stem cells.
Cancer Lett. 341:41–45. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xie M, Zhang L, He CS, et al: Activation
of Notch-1 enhances epithelial-mesenchymal transition in
gefitinib-acquired resistant lung cancer cells. J Cell Biochem.
113:1501–1513. 2012.
|
|
33
|
Ghajar CM and Bissell MJ: Extracellular
matrix control of mammary gland morphogenesis and tumorigenesis:
insights from imaging. Histochem Cell Biol. 130:1105–1118. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Park J and Schwarzbauer JE: Mammary
epithelial cell interactions with fibronectin stimulate
epithelial-mesenchymal transition. Oncogene. 33:1649–1657. 2014.
View Article : Google Scholar :
|
|
35
|
Bonnet D and Dick JE: Human acute myeloid
leukemia is organized as a hierarchy that originates from a
primitive hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li C, Heidt DG, Dalerba P, et al:
Identification of pancreatic cancer stem cells. Cancer Res.
67:1030–1037. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mallini P, Lennard T, Kirby J and Meeson
A: Epithelial-to-mesenchymal transition: what is the impact on
breast cancer stem cells and drug resistance. Cancer Treat Rev.
40:341–348. 2014. View Article : Google Scholar
|
|
39
|
Castellanos JA, Merchant NB and
Nagathihalli NS: Emerging targets in pancreatic cancer:
epithelial-mesenchymal transition and cancer stem cells. Onco
Targets Ther. 6:1261–1267. 2013.PubMed/NCBI
|
|
40
|
Takebe N, Warren RQ and Ivy SP: Breast
cancer growth and metastasis: interplay between cancer stem cells,
embryonic signaling pathways and epithelial-to-mesenchymal
transition. Breast Cancer Res. 13:2112011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Espinoza I, Pochampally R, Xing F, Watabe
K and Miele L: Notch signaling: targeting cancer stem cells and
epithelial-to-mesenchymal transition. Onco Targets Ther.
6:1249–1259. 2013.PubMed/NCBI
|
|
42
|
McGowan PM, Simedrea C, Ribot EJ, et al:
Notch1 inhibition alters the CD44hi/CD24lo population and reduces
the formation of brain metastases from breast cancer. Mol Cancer
Res. 9:834–844. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Soriano JV, Uyttendaele H, Kitajewski J
and Montesano R: Expression of an activated Notch4(int-3)
oncoprotein disrupts morphogenesis and induces an invasive
phenotype in mammary epithelial cells in vitro. Int J Cancer.
86:652–659. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Dontu G, Jackson KW, McNicholas E,
Kawamura MJ, Abdallah WM and Wicha MS: Role of Notch signaling in
cell-fate determination of human mammary stem/progenitor cells.
Breast Cancer Res. 6:R605–R615. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
45
|
Bellavia D, Checquolo S, Campese AF, Felli
MP, Gulino A and Screpanti I: Notch3: from subtle structural
differences to functional diversity. Oncogene. 27:5092–5098. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Guo S, Liu M and Gonzalez-Perez RR: Role
of Notch and its oncogenic signaling crosstalk in breast cancer.
Biochim Biophys Acta. 1815:197–213. 2011.PubMed/NCBI
|
|
47
|
Lin JT, Wang JY, Chen MK, et al: Colon
cancer mesenchymal stem cells modulate the tumorigenicity of colon
cancer through interleukin 6. Exp Cell Res. 319:2216–2229. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wang H, Tian Y, Wang J, et al:
Inflammatory cytokines induce NOTCH signaling in nucleus pulposus
cells: implications in intervertebral disc degeneration. J Biol
Chem. 288:16761–16774. 2013. View Article : Google Scholar : PubMed/NCBI
|
